If you need more lookups,
subscriptions start at $34 USD/month.
Debra Webster Location
United States
Debra Webster Work
2025 -now Senior Vice President, Global Regulatory Strategy @
2024 -2025 Vice President Global Regulatory Strategy @
2023 -2024 Vice President Regulatory Affairs @
2021 -2023 Vice President, Regulatory Affairs and Medical Writing @
2020 -2021 Senior Director Regulatory Affairs @
2018 -2020 Director, Advanced Therapy Medicinal Product Development @
2016 -2018 Principal Scientist, Regulatory Affairs and Product Development @ Cardinal Health Regulatory Sciences
2010 -2013 Senior Associate, Clinical Research @ Beckloff Associates
2007 -2010 Senior Medical Writer @
1992 -2007 Nonclinical and Regulatory Consultant @ Private Practice
1987 -1992 Reviewing Pharmacologist @
Debra Webster Education
Virgina Commonwealth University/Medical College of Virginia
PhD (Pharmacology/Toxicology)
1981-1985
Virginia Tech
Bachelor's Degree (Biology)
1976-1980
Debra Webster Skills
Clinical Development
Medical Writing
IND
GLP
Clinical Research
Regulatory Affairs
Pharmaceutical Industry
GCP
Regulatory Submissions
Clinical Study Design
Oncology
FDA
Clinical Trials
eCTD submission
Regenerative Medicine
Nonclinical Development
NDA submission
Project Management
Team Leadership
Formal meetings with FDA
Biotechnology
Drug Development
Life Sciences
SOP
U.S. Food and Drug Administration (FDA)
u.s. Food and Drug Administration Fda
u.s. Food and Drug Administration
Debra Webster Summary
Debra Webster, based in United States, is currently a Senior Vice President, Global Regulatory Strategy at SSI Strategy. Debra Webster brings experience from previous roles at SSI Strategy, Aditum Bio and BlueRock Therapeutics. Debra Webster holds a 1981 - 1985 PhD in Pharmacology/Toxicology @ Virgina Commonwealth University/Medical College of Virginia. With a robust skill set that includes Clinical Development, Medical Writing, IND, GLP, Clinical Research and more.
Looking for a different Debra Webster?
Find contact details for 700 million professionals.